Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Corporate & Other — Unallocated Operating Loss by Year
Corporate & Other — Unallocated Operating Loss ($M)
Elevance Health Corporate & Other — Unallocated Operating Loss: -$337M in FY2025, down 73.5% from a year earlier.
Latest, FY2025
-337
Period ended Dec 31, 2025
Change on a year earlier
-73.5%
-1,270 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Operating gain (loss) | $ | 4,158 | $ | 2,418 | $ | 960 | $ | 3,378 | $ | ( 337 ) | $ | — | $ | 7,199”
Source: 10-K (FY2025, 2026-02-06) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Corporate & Other — Unallocated Operating Loss ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -337 | -73.5% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2024 | Dec 31, 2024 | -1,270 | -25,500.0% | 10-K (FY2025, 2026-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 5 | -100.5% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| FY2022 | Dec 31, 2022 | -1,044 | +933.7% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| FY2021 | Dec 31, 2021 | -101 | – | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
Cite this data
StockData. (2026). Elevance Health Corporate & Other — Unallocated Operating Loss ($M), annual FY2021–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-corporate-other
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.